---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-050488"
form_type: "8-K"
ticker: "ICCC"
cik: "0000811641"
company_name: "IMMUCELL CORP /DE/"
filed_at: "2023-06-21T23:59:59+00:00"
generated_at: "2026-06-13T20:24:49.280574+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# ImmuCell appoints Bryan Gathagan to board; board extends rights plan despite advisory vote failure

## Summary
- Bryan K. Gathagan appointed independent director effective June 16, 2023; appointed to Audit Committee.
- Non-binding advisory vote on extending rights plan by one year failed with 42% of shares present, but 65% of votes cast in favor.
- Board extended Common Stock Rights Plan to September 19, 2024 despite advisory vote failure.
- All six director nominees elected; Wipfli LLP ratified as auditor for FY2023.
- 5.7M shares represented (73% of outstanding) at annual meeting.

## SEC filing metadata
- accession: 0001213900-23-050488
- form_type: 8-K
- ticker: ICCC
- cik: 0000811641
- company_name: IMMUCELL CORP /DE/
- filed_at: 2023-06-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/0001213900-23-050488-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/ea180740-8k_immucell.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-050488
- JSON: https://secwatch.observer/filing/0001213900-23-050488.json
- Plain text: https://secwatch.observer/filing/0001213900-23-050488.txt

## Key facts
- Executive change
  Bryan K. Gathagan was elected as independent director at IMMUCELL CORP /DE/.
  - Action: elected
  - Role: independent director
  source text: Pursuant to a recommendation by the Nominating Committee, the board of directors (the “Board”) of ImmuCell Corporation (the “Company”) elected Mr. Bryan K. Gathagan as an independent director, effective June 16, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/0001213900-23-050488-index.htm
- Shareholder Votes
  IMMUCELL CORP /DE/ shareholders approved To approve a non-binding advisory resolution on the Company’s executive compensation program. at the 2023-06-15 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: 2. To approve a non-binding advisory resolution on the Company’s executive compensation program: For Against Abstain Broker Non-votes 3,293,046 76,241 303,370 2,032,888
  evidence_url: https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/0001213900-23-050488-index.htm
- Shareholder Votes
  IMMUCELL CORP /DE/ shareholders approved To ratify the Audit Committee’s selection of Wipfli LLP as the Independent Registered Public Accounting Firm of the Company for the year ending December 31, 2023. at the 2023-06-15 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: 4. To ratify the Audit Committee’s selection of Wipfli LLP as the Independent Registered Public Accounting Firm of the Company for the year ending December 31, 2023: For Against Abstain Broker Non-votes 5,687,633 9,343 8,569 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/0001213900-23-050488-index.htm
- Shareholder Votes
  IMMUCELL CORP /DE/ shareholders approved To elect to one-year terms as Directors of the Company the six nominees listed in the 2023 Proxy Statement. at the 2023-06-15 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: 1. To elect to one-year terms as Directors of the Company the nominees listed in the Company’s Proxy Statement dated April 28, 2023: For Withheld Broker Non-votes Gloria J. Basse 3,594,248 78,409 2,032,888 Michael F. Brigham 3,590,547 82,110 2,032,888 Bobbi Jo Brockmann 3,614,602 58,055 2,032,888 Steven T. Rosgen 3,592,944 79,713 2,032,888 David S. Tomsche 3,555,331 117,326 2,032,888 Paul R. Wainman 3,547,166 125,491 2,032,888
  evidence_url: https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/0001213900-23-050488-index.htm
- Shareholder Votes
  IMMUCELL CORP /DE/ shareholders rejected To approve a non-binding advisory vote on whether to amend the Company’s Common Stock Rights Plan extending its expiration date by one year to September 19, 2024. at the 2023-06-15 meeting.
  - Proposal: say on pay
  - Outcome: failed
  - Meeting: 2023-06-15
  source text: 3. To approve a non-binding advisory vote on whether to amend the Company’s Common Stock Rights Plan extending its expiration by one year to September 19, 2024: For Against Abstain Broker Non-votes 2,390,931 1,270,796 10,930 2,032,888
  evidence_url: https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/0001213900-23-050488-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.